However, a recent retrospective genome‐wide association study has revealed that human LRMDA gene has been implicated as a potential locus in non‐European patients susceptible to COVID‐19.[52] In addition, TRPV2 has been reported to be associated with the spike protein of and mediate the entry of SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus‐2) into macrophages.[53] Our data showed that a portion of LRMDA was located closely to the cell membrane and potentially involved in the cytoskeleton remodeling pathways. The gene discussed is TRPV2; the disease is COVID-19.